Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICI
NCT06100796
·
clinicaltrials.gov ↗
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer Metastatic
Diabetes Mellitus
Interventions
COMBINATION_PRODUCT:
Pembrolizumab
Sponsor
Assiut University